Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
---|---|---|---|---|---|---|
Q3 2024 | 9 | 260,560 | BEAM, RAPP, ERAS, QTTB | 13F-HR | 11/14/2024 | 000101297524000476 |
Q2 2024 | 9 | 266,023 | BEAM, RAPPORT THERAPEUTICS, INC., ERAS, VERV | 13F-HR | 8/14/2024 | 000101297524000339 |
Q1 2024 | 8 | 80,276 | VERV, ERAS, GOSS, DNLI | 13F-HR | 5/15/2024 | 000101297524000230 |
Q4 2023 | 7 | 163,507 | RVMD, VERV, ERAS, DNLI | 13F-HR | 2/14/2024 | 000101297524000083 |
Q3 2023 | 7 | 153,960 | EQRX, VERV, ERAS, DNLI | 13F-HR | 11/14/2023 | 000101297523000461 |
Q2 2023 | 6 | 161,950 | EQRX, VERV, ERAS, DNLI | 13F-HR | 8/9/2023 | 000101297523000327 |
Q1 2023 | 8 | 207,180 | EQRX, DNLI, ERAS, VERV | 13F-HR | 5/15/2023 | 000101297523000217 |
Q4 2022 | 8 | 390,418 | DNLI, KRTX, EQRX, ERAS | 13F-HR | 2/14/2023 | 000101297523000091 |
Q3 2022 | 10 | 771,381 | KRTX, EQRX, DNLI, ERAS | 13F-HR | 11/10/2022 | 000101297522000487 |
Q2 2022 | 10 | 820,637 | KRTX, EQRX, DNLI, ERAS | 13F-HR | 8/15/2022 | 000101297522000354 |
Q1 2022 | 8 | 699,754 | KRTX, EQRX, ERAS, VERV | RESTATEMENT | 5/27/2022 | 000101297522000255 |
Q4 2021 | 9 | 945,256 | KRTX, EQRX, ERAS, VERV | 13F-HR | 2/14/2022 | 000101297522000080 |
Q3 2020 | 3 | 20,032 | RUBY, CHMA, SYRS | 13F-HR | 11/16/2020 | 000101297520000837 |
Q2 2020 | 4 | 29,724 | RUBY, CHMA, SYRS, KURA | 13F-HR | 8/12/2020 | 000101297520000678 |
Q1 2020 | 5 | 59,229 | IOTS, SYRS, RUBY, CHMA | 13F-HR | 5/6/2020 | 000101297520000401 |
Q4 2019 | 5 | 76,733 | RUBY, SYRS, IOTS, CHMA | 13F-HR | 2/5/2020 | 000151284820000003 |
Q3 2019 | 5 | 91,368 | SYRS, RUBY, KURA, FATE | 13F-HR | 11/12/2019 | 000101297519000673 |
Q2 2019 | 4 | 96,589 | RUBY, KURA, FATE, CHMA | 13F-HR | 8/9/2019 | 000101297519000544 |
Q1 2019 | 6 | 103,550 | RUBY, KURA, FATE, CHMA | 13F-HR | 5/14/2019 | 000101297519000343 |
Q4 2018 | 1 | 774 | BLPH | NEW HOLDINGS | 5/17/2019 | 000101297519000385 |
Q4 2018 | 5 | 99,255 | RUBY, FATE, KURA, CHMA | 13F-HR | 2/14/2019 | 000101297519000162 |